These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 31743768

  • 21. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P.
    Oncotarget; 2017 May 23; 8(21):34468-34480. PubMed ID: 28380431
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X, Zou X, Liu C, Cheng W, Zhang S, Geng X, Zhu W.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34076696
    [Abstract] [Full Text] [Related]

  • 23. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
    Zhuo X, Zhou W, Li D, Chang A, Wang Y, Wu Y, Zhou Q.
    Cancer Biomark; 2018 Jun 25; 23(4):579-587. PubMed ID: 30475754
    [Abstract] [Full Text] [Related]

  • 24. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    Wu L, Zheng K, Yan C, Pan X, Liu Y, Liu J, Wang F, Guo W, He X, Li J, Shen Y.
    BMC Cancer; 2019 Aug 28; 19(1):843. PubMed ID: 31455274
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X.
    Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225
    [Abstract] [Full Text] [Related]

  • 30. Plasma microRNA signature of patients with IgA nephropathy.
    Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C.
    Gene; 2018 Apr 05; 649():80-86. PubMed ID: 29459010
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
    Zou X, Gao F, Wang ZY, Zhang H, Liu QX, Jiang L, Zhou X, Zhu W.
    Chin Med J (Engl); 2020 Nov 05; 133(21):2543-2551. PubMed ID: 33009019
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z, Zhao Y.
    BMC Cancer; 2019 Jan 24; 19(1):104. PubMed ID: 30678643
    [Abstract] [Full Text] [Related]

  • 36. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
    Wang Z, Lv J, Zou X, Huang Z, Zhang H, Liu Q, Jiang L, Zhou X, Zhu W.
    Gene; 2019 Apr 20; 693():37-45. PubMed ID: 30684524
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 20; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C, Chen J, Xie S, Zhang L, Xiang Y, Lung M, Kam NW, Kwong DL, Cao S, Guan XY.
    Int J Cancer; 2018 Dec 15; 143(12):3209-3217. PubMed ID: 29971780
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
    Wardana T, Oktriani R, Murjayanto CH, Putri DU, Anwar SL, Aryandono T, Haryana SM.
    Microrna; 2023 Dec 15; 12(1):29-44. PubMed ID: 36121076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.